Yüklüyor......

ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系

BACKGROUND AND OBJECTIVE: Anaplastic lymphoma kinase (ALK) is one of the major driver genes of non-small cell lung cancer (NSCLC). Several studies have shown that the efficacy of pemetrexed in ALK-positive lung cancer is controversial. The aim of this study is to explore the efficacy of pemetrexed-b...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Zhongguo Fei Ai Za Zhi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 中国肺癌杂志编辑部 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5973278/
https://ncbi.nlm.nih.gov/pubmed/29167001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.02
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!